Piscataway, NJ, United States of America

Paul G Mattner

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul G Mattner. Retrieved from https://idiyas.com/inventor/paul-g-mattner-lbjeixtw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paul G. Mattner

Introduction

Paul G. Mattner is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of conjugates that enhance drug solubility and efficacy. His work is characterized by a commitment to improving existing processes and creating innovative solutions.

Latest Patents

One of Paul G. Mattner's key patents is titled "Improved process for preparing polymyxin B/dextran conjugates." This patent describes an improved method for producing a water-soluble polymyxin B/dextran conjugate. The process involves reacting polymyxin B or a pharmaceutically acceptable salt thereof with dextran in an aqueous medium at a pH of about 9.3 to 10. This innovation has the potential to enhance the therapeutic applications of polymyxin B.

Career Highlights

Paul G. Mattner is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative pharmaceutical solutions that address critical health challenges. With a total of 1 patent to his name, he continues to contribute to advancements in drug formulation and delivery.

Collaborations

Throughout his career, Paul has collaborated with several talented individuals, including Prasad Koteswara Kapa and Gleb Kardash. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

Paul G. Mattner's contributions to the field of pharmaceuticals exemplify the spirit of innovation and dedication to improving healthcare. His work on polymyxin B/dextran conjugates showcases his ability to enhance drug formulations, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…